<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Allos S.a. — News on 6ix</title>
    <link>https://6ix.com/company/allos-sa</link>
    <description>Latest news and press releases for Allos S.a. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 11 Mar 2026 00:02:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/allos-sa" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d59adfbeedb30cb6f947a3.webp</url>
      <title>Allos S.a.</title>
      <link>https://6ix.com/company/allos-sa</link>
    </image>
    <item>
      <title>EBITDA GROWS 7.5% ACHIEVING A RECORD MARGIN OF 79%</title>
      <link>https://6ix.com/company/allos-sa/news/ebitda-grows-75percent-achieving-a-record-margin-of-79percent</link>
      <guid isPermaLink="true">https://6ix.com/company/allos-sa/news/ebitda-grows-75percent-achieving-a-record-margin-of-79percent</guid>
      <pubDate>Wed, 11 Mar 2026 00:02:00 GMT</pubDate>
      <description>ALLOS S.A. announces its results for the fourth quarter of 2025 (4Q25). At the end of 4Q25, the Company held interest in 45 malls, totaling 1,938 thousand sqm of Total GLA and 1,265 thousand sqm of Owned GLA and provided planning, management and leasing services to 6 third-party malls with a total GLA of 190 thousand sqm.</description>
    </item>
    <item>
      <title>Allos Raises $5M to Apply Causal AI Across Complex Drug Reformulation</title>
      <link>https://6ix.com/company/allos-sa/news/allos-raises-dollar5m-to-apply-causal-ai-across-complex-drug-reformulation</link>
      <guid isPermaLink="true">https://6ix.com/company/allos-sa/news/allos-raises-dollar5m-to-apply-causal-ai-across-complex-drug-reformulation</guid>
      <pubDate>Mon, 12 Jan 2026 14:00:00 GMT</pubDate>
      <description>Allos AI today announced $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry&apos;s first &quot;glass-box&quot; Causal AI platform, accelerating the end-to-end reformulation of complex generic drugs. The round also included participation from Habico Invest, the family office of Danish pharmaceutical group Orifarm, and the University of California accelerator Berkeley SKYDECK. The funding will support expansion across formulation development and data science as the</description>
    </item>
    <item>
      <title>Allos Pharma Acquires Global Rights to Arbaclofen, Reports Positive ASD Trial Results and Grant Award</title>
      <link>https://6ix.com/company/allos-sa/news/allos-pharma-acquires-global-rights-to-arbaclofen-reports-positive-asd-trial-results-and-grant-award</link>
      <guid isPermaLink="true">https://6ix.com/company/allos-sa/news/allos-pharma-acquires-global-rights-to-arbaclofen-reports-positive-asd-trial-results-and-grant-award</guid>
      <pubDate>Thu, 21 Aug 2025 12:00:00 GMT</pubDate>
      <description>Allos Pharma Inc., announces key milestones advancing its mission to deliver effective treatments for Autism Spectrum Disorder (ASD), Fragile X Syndrome, and related neurodevelopmental disorders.</description>
    </item>
    <item>
      <title>ALLOS 2Q25 RESULTS: SSS +7.1%, SSR +7.7% and FFOPS+9%</title>
      <link>https://6ix.com/company/allos-sa/news/allos-2q25-results-sss-71percent-ssr-77percent-and-ffops9percent</link>
      <guid isPermaLink="true">https://6ix.com/company/allos-sa/news/allos-2q25-results-sss-71percent-ssr-77percent-and-ffops9percent</guid>
      <pubDate>Wed, 13 Aug 2025 22:58:00 GMT</pubDate>
      <description>ALLOS S.A. (B3: ALOS3), the most complete experience, entertainment, services, lifestyle and shopping platform in Latin America announces its results for the second quarter of 2025 (2Q25). At the end of 2Q25, the Company held ownership of 45 malls, totalling 1,909 thousand sqm of Total GLA and 1,242 thousand sqm of Owned GLA. The Company also provided planning, management, and leasing services to 10 third-party malls with a total GLA of 296 Thousand sqm.</description>
    </item>
  </channel>
</rss>